The effects of β-(TYR9)melanotropin-(9-18) and H-PHE-ILE-TYR-HIS-SER-TYR-LYS-OH on the analgesic action of morphine

G. Telegdy, L. Vécsei, A. V. Schally, D. H. Coy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

β-(Tyr9)melanotropin-(9-18), which itself has no analgesic action, as measured by the tail-flick and hot-plate methods, decreased morphine-induced analgesia following intracerebroventricular injection. H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH heptapeptide, which has weak CRF-like activity, had no action on analgesia and was not able to modify morphine-induced analgesia. Compared with ACTH1-24, which in a subcutaneous dose of 100 μg/rat decreased morphine-induced analgesia, the same dose of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH was ineffective.

Original languageEnglish
Pages (from-to)131-134
Number of pages4
JournalNeuropharmacology
Volume22
Issue number1
DOIs
Publication statusPublished - 1983

Fingerprint

Melanocyte-Stimulating Hormones
Analgesia
Morphine
Analgesics
Tail
Injections
H-phenylalanyl-isoleucyl-tyrosyl-histidyl-seryl-tyrosyl-lysine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

The effects of β-(TYR9)melanotropin-(9-18) and H-PHE-ILE-TYR-HIS-SER-TYR-LYS-OH on the analgesic action of morphine. / Telegdy, G.; Vécsei, L.; Schally, A. V.; Coy, D. H.

In: Neuropharmacology, Vol. 22, No. 1, 1983, p. 131-134.

Research output: Contribution to journalArticle

@article{ba5e9b66faf649fbac49cdded64bad00,
title = "The effects of β-(TYR9)melanotropin-(9-18) and H-PHE-ILE-TYR-HIS-SER-TYR-LYS-OH on the analgesic action of morphine",
abstract = "β-(Tyr9)melanotropin-(9-18), which itself has no analgesic action, as measured by the tail-flick and hot-plate methods, decreased morphine-induced analgesia following intracerebroventricular injection. H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH heptapeptide, which has weak CRF-like activity, had no action on analgesia and was not able to modify morphine-induced analgesia. Compared with ACTH1-24, which in a subcutaneous dose of 100 μg/rat decreased morphine-induced analgesia, the same dose of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH was ineffective.",
author = "G. Telegdy and L. V{\'e}csei and Schally, {A. V.} and Coy, {D. H.}",
year = "1983",
doi = "10.1016/0028-3908(83)90273-3",
language = "English",
volume = "22",
pages = "131--134",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - The effects of β-(TYR9)melanotropin-(9-18) and H-PHE-ILE-TYR-HIS-SER-TYR-LYS-OH on the analgesic action of morphine

AU - Telegdy, G.

AU - Vécsei, L.

AU - Schally, A. V.

AU - Coy, D. H.

PY - 1983

Y1 - 1983

N2 - β-(Tyr9)melanotropin-(9-18), which itself has no analgesic action, as measured by the tail-flick and hot-plate methods, decreased morphine-induced analgesia following intracerebroventricular injection. H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH heptapeptide, which has weak CRF-like activity, had no action on analgesia and was not able to modify morphine-induced analgesia. Compared with ACTH1-24, which in a subcutaneous dose of 100 μg/rat decreased morphine-induced analgesia, the same dose of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH was ineffective.

AB - β-(Tyr9)melanotropin-(9-18), which itself has no analgesic action, as measured by the tail-flick and hot-plate methods, decreased morphine-induced analgesia following intracerebroventricular injection. H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH heptapeptide, which has weak CRF-like activity, had no action on analgesia and was not able to modify morphine-induced analgesia. Compared with ACTH1-24, which in a subcutaneous dose of 100 μg/rat decreased morphine-induced analgesia, the same dose of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH was ineffective.

UR - http://www.scopus.com/inward/record.url?scp=0020647193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020647193&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(83)90273-3

DO - 10.1016/0028-3908(83)90273-3

M3 - Article

C2 - 6302543

AN - SCOPUS:0020647193

VL - 22

SP - 131

EP - 134

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 1

ER -